ALX Oncology Holdings Inc. (ALXO): Price and Financial Metrics Recent IPO

ALX Oncology Holdings Inc. (ALXO) Recent IPO

Today's Latest Price: $75.21 USD

7.07 (-8.59%)

Updated Nov 24 4:00pm

Add ALXO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ALXO Stock Price Chart Interactive Chart >

Price chart for ALXO

ALXO Price/Volume Stats

Current price $75.21 52-week high $88.90
Prev. close $82.28 52-week low $28.01
Day low $74.74 Volume 181,200
Day high $88.71 Avg. volume 150,538
50-day MA $44.47 Dividend yield N/A
200-day MA $0.00 Market Cap 2.79B

ALX Oncology Holdings Inc. (ALXO) Company Bio

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia on April 1, 2020 and is headquartered in Burlingame, CA.

ALXO Latest News Stream

Event/Time News Detail
Loading, please wait...

ALXO Latest Social Stream

Loading social stream, please wait...

View Full ALXO Social Stream

Latest ALXO News From Around the Web

Below are the latest news stories about Alx Oncology Holdings Inc that investors may wish to consider to help them evaluate ALXO as an investment opportunity.

Applied DNA's COVID-19 Vaccine, And Other News: The Good, Bad And Ugly Of Biopharma

Applied DNA reports positive preclinical results for COVID-19 vaccine Applied DNA Sciences Inc. (APDN) announced that its COVID-19 vaccine candidate has yielded robust antibody and T-cell responses even at very low doses of linear DNA. The company is collaborating with Takis Biotech for developing this vaccine. Both the companies believe...

Avisol Capital Partners on Seeking Alpha | July 20, 2020

ALX Oncology prices IPO at $19

ALX Oncology (ALXO) has priced its IPO of 8.5M common shares at $19.00/share, for expected gross proceeds of $161.5M.Underwriters' over-allotment is an additional 1,275,000 shares.Trading kicks off on July 17.Closing date is July 21.Previously: ALX Oncology on deck for IPO (June 27)...

Seeking Alpha | July 17, 2020

Read More 'ALXO' Stories Here

ALXO Price Returns

1-mo 80.97%
3-mo 70.62%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.645 seconds.